Stockreport

ACADIA Pharmaceuticals Inc (ACAD) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF DAYBUE Net Sales: $101.1 million, marking the highest revenue and prescription volume since launch. NUPLAZID Net Sales: $177.5 million, representing a 12% year-over-y [Read more]